Published: Last 2 Years Category: All Categories Life Sciences Pharmaceuticals Biopharmaceuticals -
Global Non-Oncology Biopharmaceuticals Market - 2025-2033
Non-Oncology Biopharmaceuticals Market - Industry Outlook Non-Oncology Biopharmaceuticals Market reached US$ 194.39 Billion in 2024 and is expected to reach US$ 313.70 Billion by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033. The global non-oncology biopharmaceuticals market i ... Read More
-
Biopharmaceutical Logistics
Global Biopharmaceutical Logistics Market to Reach US$143.9 Billion by 2030 The global market for Biopharmaceutical Logistics estimated at US$108.6 Billion in the year 2024, is expected to reach US$143.9 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logist ... Read More
-
Need some help finding the right information ?Verify before you buy
or call us
US toll free: 800.298.5699
Worldwide: +1.240.747.3093
-
Bioburden Testing
Global Bioburden Testing Market to Reach US$2.3 Billion by 2030 The global market for Bioburden Testing estimated at US$1.2 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 11.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed ... Read More
-
Biologics
Global Biologics Market to Reach US$732.4 Billion by 2030 The global market for Biologics estimated at US$455.4 Billion in the year 2024, is expected to reach US$732.4 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments ... Read More
-
Erythropoietin Drugs
Global Erythropoietin Drugs Market to Reach US$17.3 Billion by 2030 The global market for Erythropoietin Drugs estimated at US$13.4 Billion in the year 2024, is expected to reach US$17.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Epoetin-alfa, one of the segments ... Read More
-
Single-Use Bioprocessing
Global Single-Use Bioprocessing Market to Reach US$80.8 Billion by 2030 The global market for Single-Use Bioprocessing estimated at US$26.1 Billion in the year 2024, is expected to reach US$80.8 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2024-2030. Single-Use Media Bags &am ... Read More
-
Biopharmaceutical Fermentation Systems
Global Biopharmaceutical Fermentation Systems Market to Reach US$19.3 Billion by 2030 The global market for Biopharmaceutical Fermentation Systems estimated at US$14.8 Billion in the year 2024, is expected to reach US$19.3 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030 ... Read More
-
PEGylated Proteins
Global PEGylated Proteins Market to Reach US$2.0 Billion by 2030 The global market for PEGylated Proteins estimated at US$1.2 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Consumables, one of the segments analyzed ... Read More
-
Spine Biologics
Global Spine Biologics Market to Reach US$2.9 Billion by 2030 The global market for Spine Biologics estimated at US$2.2 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed ... Read More
-
Bioreactors and Fermenters
Global Bioreactors and Fermenters Market to Reach US$6.7 Billion by 2030 The global market for Bioreactors and Fermenters estimated at US$3.6 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Single-use Bioreactors, ... Read More
-
Mexico Biosimilars Market Overview, 2030
An increase in awareness and acceptance of biosimilars among healthcare professionals in Mexico is another significant trend that is fueling market growth. Previously, physicians and healthcare professionals were somewhat hesitant to transition from originator biologics to biosimilars because they w ... Read More
-
India Biosimilars Market Overview, 2030
Biosimilars, a category of biological medical products, closely emulate original reference biologic drugs, ensuring comparable safety, purity, and potency without clinically significant differences. Unlike generic drugs, which are exact copies of small-molecule chemical drugs, biosimilars cannot rep ... Read More
-
Brazil Biosimilars Market Overview, 2030
The Brazil Biosimilars market will grow with The increased incidence of chronic illnesses, rising healthcare expenses, and the demand for affordable biologic medicine substitutes. Brazil is the ninth-largest economy in the world, and it boasts one of the biggest and most complicated healthcare syste ... Read More
-
Europe Biosimilars Market Outlook, 2030
Europe has played a pioneering role in the development, approval, and adoption of biosimilars, being the first region globally to establish a regulatory pathway for these drugs with the European Medicines Agency (EMA) issuing the first biosimilar approval in 2006. Since then, the European market has ... Read More
-
Australia Biosimilars Market Overview, 2030
The regulatory body for therapeutic goods in Australia is the Therapeutic Goods Administration (TGA). TGA is a division of the Australian Government Department of Health and Ageing, and is responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products, in ... Read More
-
Global Biosimilars Market Overview, 2025-30
Biosimilars are safe, effective, and highly similar versions of approved and authorized biologics. A biological drug is a large and complex protein produced from living cells through complex manufacturing processes. As patents for many blockbuster biologics expire, biosimilars present an opportunity ... Read More
-
Germany Biosimilars Market Overview, 2030
Biosimilars are biological drugs that are extremely similar to a reference drug, a biological drug that has already received approval. They are designed to be equally safe and effective as the reference drug. The European Medicines Agency (EMA), which establishes standards for their research and app ... Read More
-
Global Biosimilars Market Outlook, 2030
BiosimilarsThe biosimilars industry has emerged as a transformative force in the global healthcare landscape, representing a vital frontier in biopharmaceutical innovation and affordability. Biosimilars are biologic medical products that are highly similar to an already approved reference biologic, ... Read More
-
Canada Biosimilars Market Overview, 2030
Potential savings from biosimilars are a subject of keen interest internationally, with a particular relevance for Canadians. Given the high use and cost of biologics in Canada, the increased use of biosimilars offers a significant opportunity for cost savings for Canadian payers. Unlike small molec ... Read More
-
China Biosimilars Market Overview, 2030
Biosimilars have played a significant role in alleviating healthcare burdens and enhancing patient access to high-quality biologic-based pharmaceutical therapies. The World Health Organization (WHO), as well as various national governments and regulatory agencies, have established corresponding regu ... Read More
-
South Africa Biosimilars Market Overview, 2030
Traditionally, the pharmaceutical market has been known for its production of chemical synthetic medicines generally referred to as originators and generic medicines. However, in the last decade, there has been an increasing interest in more technologically advanced and effective medicines such as b ... Read More
-
Asia-Pacific Biosimilars Market Outlook, 2030
The Asia Pacific region, comprising countries such as China, India, Japan, South Korea, Australia, and Southeast Asian nations, plays an increasingly pivotal role in the global biosimilars market due to its growing manufacturing capabilities, improving regulatory frameworks, and expanding patient ba ... Read More
-
United Kingdom Biosimilars Market Overview, 2030
Biosimilars are a type of biological medicine and are widely used in the UK for many conditions. Biological medicines are complex medicines made or derived from a biological source. The biosimilar contains a version of an active substance of an already approved biological medicinal product, known as ... Read More
-
Japan Biosimilars Market Overview, 2030
Biosimilars are pharmaceutical medications that are highly similar to an existing biological reference product, known as the originator or reference biologic. Biosimilars are designed to be comparable in quality, safety, and efficacy to the reference product while being less expensive. They are an a ... Read More
-
Columbia Biosimilars Market Overview, 2030
Colombia is emerging as a key player, thanks to its agile regulatory framework, an active authority such as INVIMA, and policies that promote access to biotechnological medicines. In recent years, Colombia has made significant regulatory advances. INVIMA has implemented measures to streamline biosim ... Read More
Research Assistance